|Cell line type
|Human induced pluripotent stem cell (hiPSC)
|17th October 2022
No feedback available yet.
Login to share your feedback, experiences or results with the research community.
|Spanish Stem Cell Bank (ES)
|Centre of Regenerative Medicine in Barcelona - Banc de Linies Cellulars (CRMB)
|* Is the cell line readily obtainable for third parties?
Research use: allowed
Clinical use: allowed
Commercial use: allowed
General Donor Information
Phenotype and Disease related information (Donor)
|A disease was diagnosed.
|Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived?
|Was the consent voluntarily given?
|Has the donor been informed that participation will not directly influence their personal treatment?
|Can you provide us with a copy of the Donor Information Sheet provided to the donor?
|Provide contact information of the holder of the original Donor Information Sheet:
|Do you (Depositor/Provider) hold the original Donor Consent Form?
|If you do not hold the Donor Consent Form, do you know who does?
|Has the donor been informed about how her/his data will be protected?
|Please indicate whether the data associated with the donated material has been pseudonymised or anonymised.
|Does consent explicitly allow the derivation of pluripotent stem cells?
|Does consent expressly prevent the derivation of pluripotent stem cells?
|Does consent pertain to a specific research project?
|Details on restriction to research project
|Does consent permit unforeseen future research, without further consent?
|Does the consent permit uses of donated embryo/tissue or derived cell line intended for clinical treatment or human applications?
|Does consent expressly permit storage of donated embryo/tissue for an unlimited time?
|Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world?
|Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world?
Does consent permit research by
|an academic institution?
|a public organisation?
|a non-profit company?
|Does consent expressly permit collection of genetic information?
|Has the donor been informed that their donated biosample or derived cells may be tested for the presence of microbiological agents / pathogens?
|How may genetic information associated with the cell line be accessed?
|Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample?
|Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples?
|Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor?
|Does consent permit access to medical records of the donor?
|Does consent permit access to any other source of information about the clinical treatment or health of the donor?
|Do you have obligations to third parties in regard to the use of the cell line?
|Are you aware of any further constraints on the use of the donated embryo/tissue or derived cells?
|Is there an MTA available for the cell line?
|For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
|Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above?
|Source cell line name
|Source cell type
A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.; These cells may be vimentin-positive, fibronectin-positive, fsp1-positive, MMP-1-positive, collagen I-positive, collagen III-positive, and alpha-SMA-negative.
|Source cell origin
A zone of skin that is part of a lower arm [Automatically generated definition].
|Source cell line vendor
|Is the used vector excisable?
|Absence of reprogramming vector(s)?
|Reprogramming vectors silenced?
Vector free reprogramming
|Selection criteria for clones
|the clones have been selecte by their morphology
|Derived under xeno-free conditions
|Derived under GMP?
|Available as clinical grade?
Cellfinder Ont Id: CELDA_000001419
Base medium: K-Dmem
Main protein source: Knock-out serum replacement
Serum concentration: 20 %
Analysis of Undifferentiated Cells
Microbiology / Virus Screening
Karyotyping (Cell Line)
|Has the cell line karyotype been analysed?
Passage number: 19
Karyotyping method: G-Banding
Other Genotyping (Cell Line)